The global demand for Nicorandil Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028. Regarding volume, the market was calculated XX Ton in 2021 and forecast to touch XX Ton by 2028 with a CAGR of XX% during 2022-2028.
Nicorandil, also known as Ikorel, is a drug that helps to decrease the risk of suffering from an angina attack by increasing the blood supply in the heart. Regular intake of the drug is also known to reduce the risk of further heart problems. The regular intake of nicorandil amounts to twice a day. The drug has several side effects, wherein the common ones include dizziness and headaches. However, they are usually mild and short-lived. The drug's severe side effects may involve watery, red or itchy eyes, conjunctivitis or a corneal ulcer, playful sores on the eyes, loss of appetite, feeling sick, stomachache, etc.
Market Dynamics
Nicorandil is a well-known antianginal drug that is often prescribed as a second-line treatment for chronic stable angina. The efficacy shown by the drug is equal to classic antianginal agents. Nicorandil has a lower adverse reaction than other drugs. A high-level recommendation from various global health organizations and applicability for numerous health conditions are the major drivers within the nicorandil market. In addition, it is a clinical alternative for several cardiovascular diseases such as unstable or variant angina, reperfusion-induced damage following coronary thrombolysis or angioplasty. This factor is also anticipated to bolster market growth. However, the number of side effects associated with the drug could significantly restrain the market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of nicorandil. The growth and trends of nicorandil industry provide a holistic approach to this study.
Market Segmentation
This section of the nicorandil market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Application
By Dosage
By Form
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Nicorandil market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Nicorandil Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the nicorandil market include Sigma Aldrich, Niksan Pharmaceutical, Aditya Chemicals, Salvavidas Pharmaceutical, Taj Pharmaceuticals, rajvi enterprise, Actiza Pharmaceutical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.